A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Uterine cervix , Vaginal fluid Canalis cervicis uteri,Caudal segment of uterus,Cervical canal,Cervical canal of uterus,Cervix,Cervix of uterus,Cervix uteri,Neck of uterus,Uterine cervix,uterine cervix,Vaginal discharge,Vaginal secretion,Vaginal fluid,vaginal fluid
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal Healthy Women & High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bacterial Vaginosis (BV) Infected Women
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with Bacterial Vaginosis (BV) Infection.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 136
- Group 1 sample size Number of subjects in the case (exposed) group
- 52
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 1 month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 4
Signature 1
Source: Figure 5A
Description: Bacterial Taxa differentially abundant in the vaginal microbiome of Bacterial Vaginosis (BV) Infected women compared to Normal healthy women & High‑risk human papillomavirus(HR-HPV) Infected Women as determined by LEfSe Analysis.
Abundance in Group 1: increased abundance in Bacterial Vaginosis (BV) Infected Women
NCBI | Quality Control | Links |
---|---|---|
Bacteroidales | ||
Bacteroidia | ||
Bacteroidota | ||
Hoylesella timonensis | ||
Prevotella | ||
Prevotellaceae |
Revision editor(s): Joan Chuks, WikiWorks
Experiment 2
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Human papilloma virus infection HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal Healthy Women & Bacterial Vaginosis (BV) Infected Women
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with High‑risk human papillomavirus (HR-HPV) infection.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 117
- Group 1 sample size Number of subjects in the case (exposed) group
- 71
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 5A
Description: Bacterial Taxa differentially abundant in the vaginal microbiome of High‑risk human papillomavirus(HR-HPV) Infected Women compared to Normal healthy women & Bacterial Vaginosis (BV) Infected Women as determined by LEfSe Analysis.
Abundance in Group 1: increased abundance in High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus iners |
Revision editor(s): Joan Chuks, WikiWorks
Experiment 3
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis , Human papilloma virus infection BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis,HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal Healthy Women
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bacterial vaginosis (BV) infected women & High‑risk human papillomavirus (HR-HPV) (HPV) infected Women
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with Bacterial vaginosis (BV) infection and those diagnosed with High‑risk human papillomavirus (HR-HPV) infection.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 65
- Group 1 sample size Number of subjects in the case (exposed) group
- 123
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 5A
Description: Bacterial Taxa differentially abundant in the vaginal microbiome of Bacterial Vaginosis (BV) infected women and High‑risk human papillomavirus (HR-HPV) infected women compared to Normal healthy women as determined by LEfSe Analysis.
Abundance in Group 1: decreased abundance in Bacterial vaginosis (BV) infected women & High‑risk human papillomavirus (HR-HPV) (HPV) infected Women
NCBI | Quality Control | Links |
---|---|---|
Bacilli | ||
Bacillota | ||
Lactobacillaceae | ||
Lactobacillales | ||
Lactobacillus |
Revision editor(s): Joan Chuks, WikiWorks
Experiment 4
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Human papilloma virus infection , Cervical intraepithelial neoplasia HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection,Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervical intraepithelial neoplasia,Cervical Intraepithelial Neoplasm,Cervical Intraepithelial Neoplasms,Cervix Intraepithelial Neoplasia,Cervix Uteri Intraepithelial Neoplasia,Intraepithelial Neoplasia of Cervix,Intraepithelial Neoplasia of Cervix Uteri,Intraepithelial Neoplasia of the Cervix,Intraepithelial Neoplasia of the Cervix Uteri,Intraepithelial Neoplasia of the Uterine Cervix,Intraepithelial Neoplasia of Uterine Cervix,Intraepithelial Neoplasia, Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,NEOPL CERVICAL INTRAEPITHELIAL,Neoplasia, Cervical Intraepithelial,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial,Uterine Cervix Intraepithelial Neoplasia,cervical intraepithelial neoplasia
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- High‑risk human papillomavirus(HR-HPV) & Cervical Intraepithelial Neoplasia(CIN) co-infected women (HC)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with infection of High‑risk human papillomavirus (HR-HPV) combined with Cervical Intraepithelial Neoplasia (CIN).
- Group 1 sample size Number of subjects in the case (exposed) group
- 48
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
Experiment 5
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis , Human papilloma virus infection , Cervical intraepithelial neoplasia BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis,HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection,Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervical intraepithelial neoplasia,Cervical Intraepithelial Neoplasm,Cervical Intraepithelial Neoplasms,Cervix Intraepithelial Neoplasia,Cervix Uteri Intraepithelial Neoplasia,Intraepithelial Neoplasia of Cervix,Intraepithelial Neoplasia of Cervix Uteri,Intraepithelial Neoplasia of the Cervix,Intraepithelial Neoplasia of the Cervix Uteri,Intraepithelial Neoplasia of the Uterine Cervix,Intraepithelial Neoplasia of Uterine Cervix,Intraepithelial Neoplasia, Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,NEOPL CERVICAL INTRAEPITHELIAL,Neoplasia, Cervical Intraepithelial,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial,Uterine Cervix Intraepithelial Neoplasia,cervical intraepithelial neoplasia
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bacteial Vaginosis (BV) & High‑risk human papillomavirus(HR-HPV) with Cervical Intraepithelial Neoplasia(CIN) co-infected women (BHC)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with co-infection of Bacteial Vaginosis (BV) & High‑risk human papillomavirus (HR-HPV) in combination with Cervical Intraepithelial Neoplasia (CIN).
- Group 1 sample size Number of subjects in the case (exposed) group
- 46
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
Experiment 6
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Human papilloma virus infection , Cervical intraepithelial neoplasia HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection,Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervical intraepithelial neoplasia,Cervical Intraepithelial Neoplasm,Cervical Intraepithelial Neoplasms,Cervix Intraepithelial Neoplasia,Cervix Uteri Intraepithelial Neoplasia,Intraepithelial Neoplasia of Cervix,Intraepithelial Neoplasia of Cervix Uteri,Intraepithelial Neoplasia of the Cervix,Intraepithelial Neoplasia of the Cervix Uteri,Intraepithelial Neoplasia of the Uterine Cervix,Intraepithelial Neoplasia of Uterine Cervix,Intraepithelial Neoplasia, Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,NEOPL CERVICAL INTRAEPITHELIAL,Neoplasia, Cervical Intraepithelial,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial,Uterine Cervix Intraepithelial Neoplasia,cervical intraepithelial neoplasia
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Bacterial Vaginosis (BV) Infected Women
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- High‑risk human papillomavirus(HR-HPV) & Cervical Intraepithelial Neoplasia(CIN) co-infected women (HC)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with infection of High‑risk human papillomavirus (HR-HPV) combined with Cervical Intraepithelial Neoplasia (CIN).
- Group 0 sample size Number of subjects in the control (unexposed) group
- 52
- Group 1 sample size Number of subjects in the case (exposed) group
- 48
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
- Richness Number of species
- decreased
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- High‑risk human papillomavirus (HR-HPV) Infected Women (HPV)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 71
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- decreased
- Richness Number of species
- decreased
Experiment 8
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis , Human papilloma virus infection BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis,HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Bacterial vaginosis (BV) and High‑risk human papillomavirus (HR-HPV) (HPV) co-infected Women (BH)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 60
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
Experiment 9
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis , Human papilloma virus infection , Cervical intraepithelial neoplasia BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis,HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection,Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervical intraepithelial neoplasia,Cervical Intraepithelial Neoplasm,Cervical Intraepithelial Neoplasms,Cervix Intraepithelial Neoplasia,Cervix Uteri Intraepithelial Neoplasia,Intraepithelial Neoplasia of Cervix,Intraepithelial Neoplasia of Cervix Uteri,Intraepithelial Neoplasia of the Cervix,Intraepithelial Neoplasia of the Cervix Uteri,Intraepithelial Neoplasia of the Uterine Cervix,Intraepithelial Neoplasia of Uterine Cervix,Intraepithelial Neoplasia, Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,NEOPL CERVICAL INTRAEPITHELIAL,Neoplasia, Cervical Intraepithelial,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial,Uterine Cervix Intraepithelial Neoplasia,cervical intraepithelial neoplasia
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bacteial Vaginosis (BV) & High‑risk human papillomavirus(HR-HPV) with Cervical Intraepithelial Neoplasia(CIN) co-infected women (BHC)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with with co-infection of Bacteial Vaginosis (BV) & High‑risk human papillomavirus (HR-HPV) in combination with Cervical Intraepithelial Neoplasia (CIN).
- Group 0 sample size Number of subjects in the control (unexposed) group
- 71
- Group 1 sample size Number of subjects in the case (exposed) group
- 46
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
Experiment 10
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- High‑risk human papillomavirus(HR-HPV) & Cervical Intraepithelial Neoplasia(CIN) co-infected women (HC)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 48
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
Experiment 11
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Normal Healthy Women
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bacterial Vaginosis (BV) Infected Women
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with Bacterial Vaginosis (BV) Infection.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 65
- Group 1 sample size Number of subjects in the case (exposed) group
- 52
Lab analysis
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- Not specified
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
Experiment 12
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Human papilloma virus infection HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with High‑risk human papillomavirus (HR-HPV) infection.
- Group 1 sample size Number of subjects in the case (exposed) group
- 71
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased
Experiment 13
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Bacterial vaginosis , Human papilloma virus infection BACT VAGINITIDES,BACT VAGINITIS,BACT VAGINOSES,BACT VAGINOSIS,Bacterial Vaginitides,Bacterial Vaginitis,Bacterial Vaginoses,bacterial vaginosis,BV,Nonspecific Vaginitis,VAGINITIDES BACT,Vaginitides, Bacterial,VAGINITIS BACT,Vaginitis, Bacterial,Vaginitis, Nonspecific,VAGINOSES BACT,Vaginoses, Bacterial,VAGINOSIS BACT,Vaginosis, Bacterial,Bacterial vaginosis,HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Bacterial vaginosis (BV) and High‑risk human papillomavirus (HR-HPV) (HPV) co-infected Women (BH)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with co-infection of Bacterial vaginosis (BV) and High‑risk human papillomavirus (HR-HPV).
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
- Richness Number of species
- increased